A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) non-small cell lung cancer (NSCLC): Update of the Alpha Oncology trial (A1-99002L).

被引：0
|
作者：
Treat, J
Belani, CP
Edelman, MJ
Socinski, MA
Ansari, RH
Obasaju, CK
Bloss, JD
Marinucci, DM
Catalano, RB
Comis, RL
机构：
[1] Fox Chase Temple Canc Ctr, Philadelphia, PA USA
[2] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[3] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[4] Univ N Carolina, Chapel Hill, NC USA
[5] Michana Hematol Oncol PC, South Bend, IN USA
[6] Lilli Oncol, Indianapolis, IN USA
[7] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1096S / 1096S
页数：1
相关论文
共 50 条
  • [1] Elderly subgroup analysis of a randomized phase 3 trial of gemcitabine (G) in combination with carboplatin (Cb) or paclitaxel (P) compared to paclitaxel plus carboplatin in advanced (stage IIIB, IV) non-small cell lung cancer (NSCLC)
    Ansari, R. H.
    Gonin, R.
    Socinski, M.
    Edelman, M.
    Catalano, R.
    Marinucci, D.
    Comis, R.
    Obasaju, C.
    Treat, J. A.
    Belani, C. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: A phase III randomized trial
    Kosmidis, P
    Mylonakis, N
    Nicolaides, C
    Kalophonos, C
    Samantas, E
    Boukovinas, J
    Fountzilas, G
    Skarlos, D
    Economopoulos, T
    Tsavdaridis, D
    Papakostas, P
    Bacoyiannis, C
    Dimopoulos, M
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) : 3578 - 3585
  • [3] A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer
    Treat, J. A.
    Gonin, R.
    Socinski, M. A.
    Edelman, M. J.
    Catalano, R. B.
    Marinucci, D. M.
    Ansari, R.
    Gillenwater, H. H.
    Rowland, K. M.
    Comis, R. L.
    Obasaju, C. K.
    Belani, C. P.
    ANNALS OF ONCOLOGY, 2010, 21 (03) : 540 - 547
  • [4] A phase II trial of alternating cycles of carboplatin/paclitaxel and carboplatin/gemcitabine for stage IIIB/IV non-small cell lung cancer
    Ahmad, I.
    Arnold, F.
    Ahmed, S.
    Sami, A.
    Zhu, T.
    Haider, K.
    Yadav, S.
    Gesy, K.
    Brigden, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] A randomized, open-label, phase III trial of NOV-002 in combination with paclitaxel (P) and carboplatin (C) versus paclitaxel and carboplatin alone for the treatment of advanced non-small cell lung cancer (NSCLC)
    Fidias, P.
    Ciuleanu, T. A.
    Gladkov, O.
    Manikhas, G. M.
    Bondarenko, I. N.
    Pluzanska, A.
    Ramlau, R.
    Lynch, T. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18)
  • [6] Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer:: a phase III randomized trial
    Zatloukal, P
    Petruzelka, L
    Zemanová, M
    Kolek, V
    Skricková, J
    Pesek, M
    Fojtu, H
    Grygárková, I
    Sixtová, D
    Roubec, J
    Horenková, E
    Havel, L
    Prusa, P
    Nováková, L
    Skácel, T
    Kuta, M
    LUNG CANCER, 2003, 41 (03) : 321 - 331
  • [7] A phase I trial of paclitaxel, carboplatin, and gemcitabine in advanced non-small cell lung cancer
    Kelly, K
    Prindiville, S
    Bunn, PA
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 74 - 74
  • [8] Randomized phase II trial of the biweekly schedule of adjuvant chemotherapy with carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with non-small cell lung cancer (NSCLC)
    Sugio, K.
    Nagashima, A.
    Nakanishi, R.
    Uchiyama, A.
    Inoue, M.
    Osaki, T.
    Yoshimatsu, T.
    Takenoyama, M.
    Hanagiri, T.
    Yasumoto, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Subgroup analysis of African American patients from a randomized phase 3 trial of gemcitabine (G) in combination with carboplatin (Cb) or paclitaxel (P) compared to P plus Cb in advanced (stage IIIB, IV) non-small cell lung cancer (NSCLC)
    Treat, J.
    Gonin, R.
    Edelman, M.
    Belani, C. P.
    Socinski, M.
    Catalano, R.
    Marinucci, D.
    Ansari, R.
    Comis, R.
    Obasaju, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Randomized phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small cell lung cancer (NSCLC)
    Saleh, M. N.
    Socinski, M. A.
    Trent, D.
    Dobbs, T.
    Zehngebot, L. M.
    Levine, M. A.
    Stella, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345